DKCM
ARRY

Davidson Kempner Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Davidson Kempner Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,805,612
Closed -$269M – 252
2019
Q2 		$269M Buy
+5,805,612
New +$163M 2.92% 8

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Davidson Kempner Capital Management's ARRY Position: Q3 2019 in Review

Davidson Kempner Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 5,805,612 shares — an estimated $269M sold.

Davidson Kempner Capital Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $269M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Davidson Kempner Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 5,805,612 Array Biopharma Inc shares in Q3 2019, an estimated $269M.
  • Davidson Kempner Capital Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Array Biopharma Inc position peaked at $269M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.